IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants.
about
Genetic prediction of common diseases. Still no help for the clinical diabetologist!Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.Lack of association between insulin receptor substrate2 rs1805097 polymorphism and the risk of colorectal and breast cancer: a meta-analysis.Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans.Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis.Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.Lack of association between the insulin receptor substrates-1 Gly972Arg polymorphism and type-2 diabetes mellitus among Saudis from Eastern Saudi ArabiaIRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk.Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities.Insulin receptor substrate-1 (IRS-1) Gly927Arg: correlation with gestational diabetes mellitus in Saudi womenRole of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease.Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population.Genetic Dissection of the Physiological Role of Skeletal Muscle in Metabolic Syndrome
P2860
Q26822607-B0E214C3-FCC2-4232-81A5-5D88DD577B62Q30571118-6A86444F-2D0F-4C61-BE97-DB105C1E54CAQ31150038-8509B415-CBB6-47E0-A3E2-37996CD95212Q33957907-B839B7C5-78F7-4A0B-ACFC-5FAD99A9938CQ34077057-7C12B570-D07B-4FCA-8AFF-3ED04197B382Q35598032-8AAACAD6-534C-45CB-9CB2-728E73F47A4FQ36448612-8176AA19-4C27-4A6E-8CD7-416DE7A59558Q36852845-DF48BE16-2E95-4E12-8F93-D38EEA4146CAQ36907969-89A59987-F7E7-4E83-AB5A-BDBD4CCB0815Q37628192-CD5DE2FB-E84F-4CED-93E4-96FB1CDF1E9DQ38050731-E2F8FB35-BE70-430F-A5DC-4F0565A27DA2Q38204372-B0F9FCCF-A6B0-48DD-A8F0-92E356DC6AABQ38684361-AA5FC213-95F5-4747-A62B-F24D2D0D2ACEQ40035063-76BFFC2B-87AB-405F-93B3-0F9BBCDE16FFQ59072667-E2FB371A-E36A-45CF-B4F3-29651E8C34DE
P2860
IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
IRS1 G972R polymorphism and ty ...... -frequency-low-risk' variants.
@en
type
label
IRS1 G972R polymorphism and ty ...... -frequency-low-risk' variants.
@en
prefLabel
IRS1 G972R polymorphism and ty ...... -frequency-low-risk' variants.
@en
P2093
P2860
P50
P1433
P1476
IRS1 G972R polymorphism and ty ...... w-frequency-low-risk' variants
@en
P2093
F Pellegrini
M Chandalia
S Mammarella
P2860
P2888
P304
P356
10.1007/S00125-009-1426-4
P50
P577
2009-06-26T00:00:00Z